February 20, 2025

18-Year Neuroblastoma Remission in a Patient After GD2 CAR T-Cell Therapy

"She has never required any other therapy and is likely the longest-surviving patient with cancer who received [CAR T-cell] therapy."

Conexiant

February 19, 2025

FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched

Mesalamine 800 mg delayed-release tablets have been launched, and FDA approval has been granted for lenalidomide, with plans for entry into the U.S. generic market in 2026.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 14, 2025

Benzene Formation in Benzoyl Peroxide: Formulation’s Role

Researchers found that benzene formation in benzoyl peroxide products is influenced by formulation factors, with hot processing increasing levels and antioxidants reducing them.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 11, 2025

Retinal Parameters Associated with Incident Stroke

"Retinal vascular analysis, a non-invasive screening approach for stroke risk assessment, performed better than traditional risk stratification models," researchers wrote.

Conexiant

February 07, 2025

Framework Reveals Cancer Reversion Switch Target

New computational system identifies USP7 as key molecular switch for reverting colorectal cancer cells to normal-like state in patient-derived organoids.

Conexiant

January 24, 2025

Understanding Cognitive Decline: Exploring the Neurological Similarities Between Alzheimer’s Disease and Chemotherapy-Related Cognitive Impairment

Researchers are uncovering the biological overlap between Alzheimer’s disease and CRCI, paving the way for innovative therapies for cognitive decline.

Conexiant

September 26, 2024

T Cell Spatial Patterns Linked to CRC Survival

Study links shorter T-cell proximity to cancer cells with improved survival rates in colorectal cancer.

Conexiant